New drug development still takes 8 years despite faster FDA review, according to Tufts CSDD

While the U.S. Food and Drug Administration Drug has quickened review and approval of new medicines, the complex nature of diseases for which new therapeutics are being developed has resulted in longer clinical development times, according to the Tufts Center for the Study of Drug Development.

Read the whole article on Physorg

More from Physorg